首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   61149篇
  免费   3917篇
  国内免费   1742篇
耳鼻咽喉   4136篇
儿科学   3167篇
妇产科学   1306篇
基础医学   5371篇
口腔科学   867篇
临床医学   5717篇
内科学   8184篇
皮肤病学   1945篇
神经病学   4711篇
特种医学   3165篇
外国民族医学   4篇
外科学   2597篇
综合类   7752篇
现状与发展   8篇
预防医学   5782篇
眼科学   617篇
药学   7194篇
  44篇
中国医学   2305篇
肿瘤学   1936篇
  2024年   90篇
  2023年   756篇
  2022年   1547篇
  2021年   2232篇
  2020年   1895篇
  2019年   1786篇
  2018年   1812篇
  2017年   1826篇
  2016年   1905篇
  2015年   2012篇
  2014年   3583篇
  2013年   4323篇
  2012年   3605篇
  2011年   3772篇
  2010年   3012篇
  2009年   2960篇
  2008年   2977篇
  2007年   3047篇
  2006年   2633篇
  2005年   2491篇
  2004年   2038篇
  2003年   1747篇
  2002年   1458篇
  2001年   1359篇
  2000年   1203篇
  1999年   1126篇
  1998年   944篇
  1997年   960篇
  1996年   813篇
  1995年   773篇
  1994年   677篇
  1993年   536篇
  1992年   550篇
  1991年   486篇
  1990年   407篇
  1989年   424篇
  1988年   402篇
  1987年   359篇
  1986年   291篇
  1985年   342篇
  1984年   260篇
  1983年   212篇
  1982年   235篇
  1981年   178篇
  1980年   156篇
  1979年   121篇
  1978年   100篇
  1977年   90篇
  1976年   71篇
  1975年   47篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
121.
122.
本文采用小鼠精子试验和小鼠睾丸DNA合成抑制试验,检测了JX-1对雄性生殖细胞的致突变作用。实验结果表明JX-1对小鼠精子总数、精子活动率及精子畸形率均无统计学意义的增加,与小鼠睾丸DNA合成抑制试验阴性反应一致。作者认为JX-1对雄性生殖细胞为一种非诱变剂。  相似文献   
123.
目的分析单侧听耳患者的鼓室成形术,了解手术方法和手术疗效。方法对9耳慢性化脓性中耳炎胆脂瘤型进行了乳突根治术加鼓室成形术,对37耳慢性化脓性中耳炎单纯型和中耳炎后遗症进行鼓室成形术,并比较术后效果。手术后3个月~1年之间进行术后听力评价。结果46耳单侧听力耳术前言语频率气导平均听阈为60.2±23.1dB HL,骨导听阈35.7±17.0dB HL;手术后的平均气导听阈为51.3±22.6dB HL,骨导听阈为36.3±10.6dB HL。鼓室成形术后疗效评定:37耳外耳道宽敞,人工鼓膜完整,血运好,近正常鼓膜色泽;纯音测听500~2000Hz平均气导听力改善23例(62.16%,23/37),听力不变13例(35.14%,13/37),听力恶化(下降10dB以上)1例(2.70%,1/37)。乳突根治术加鼓室成形术后疗效评定:9耳术腔干洁,人工鼓膜完整,血运好,近正常鼓膜色;纯音测听500~2000Hz平均气导听力改善5例(56.56%,5/9),听力不变4例(44.44%,4/9)。结论各型慢性化脓性中耳炎都可作为单侧听力耳的手术适应症。手术时只要注意手术技巧,认真仔细,一般不会造成手术后骨导听力的下降。术后干耳和保持原有听力是手术的最终目的。  相似文献   
124.
本文报告乳腺积乳囊肿43例。讨论了发病原因及病理,特别提出局部肿块波动感试验阳性,A超检查显示液平段,试穿抽出乳汁,对诊断有肯定价值;治疗以手术切除为主,仅有7例穿刺抽吸乳汁得以治愈。  相似文献   
125.
Development of a disease screening biomarker involves several phases. In phase 2 its sensitivity and specificity is compared with established thresholds for minimally acceptable performance. Since we anticipate that most candidate markers will not prove to be useful and availability of specimens and funding is limited, early termination of a study is appropriate, if accumulating data indicate that the marker is inadequate. Yet, for markers that complete phase 2, we seek estimates of sensitivity and specificity to proceed with the design of subsequent phase 3 studies. We suggest early stopping criteria and estimation procedures that adjust for bias caused by the early termination option. An important aspect of our approach is to focus on properties of estimates conditional on reaching full study enrollment. We propose the conditional‐UMVUE and contrast it with other estimates, including naïve estimators, the well‐studied unconditional‐UMVUE and the mean and median Whitehead‐adjusted estimators. The conditional‐UMVUE appears to be a very good choice. Copyright © 2008 John Wiley & Sons, Ltd.  相似文献   
126.
127.
中美中学生对由父母原因引起的考试焦虑认知研究   总被引:1,自引:0,他引:1  
目的:比较中国和美国的中学生对由父母原因引起的考试焦虑的认知情况。方法:采用“失败结果预期(FOE)”问卷中的由父母原因引起的考试焦虑12项,测量中美两国公立学校14、15岁的1215名中学生对考试焦虑原因的认知。结果:1.相似认知:两国学生在由父母原因引起的考试焦虑方面有类似的认知,包括父母会担心自己能否进入高一级学校、会让父母烦恼等。2.跨文化的差异:表现为中国学生更多是因为父母责备、辜负了父母期望或会让父母生气而导致考试焦虑;而美国学生更多是由于父母认为他们不能面对生活中的挑战而产生焦虑。3.性别差异:表现在美国的女中学生在7个项目上、中国的男中学生在2个项目上分别比本国异性有更大程度的焦虑(P〈0.05)。结论:中美中学生对由父母原因引起的考试焦虑方面有类似的认知,但存在文化差异和性别差异。  相似文献   
128.
Background BMS-747158-02 is a novel fluorine 18-labeled pyridazinone derivative designed for cardiac imaging. The uptake and retention mechanisms of F-18 BMS-747158-02 in cardiac myocytes were studied in vitro, and the biodistribution of F-18 BMS-747158-02 was studied in vivo in mice. Methods and Results Fluorine 19 BMS-747158-01 inhibited mitochondrial complex I (MC-I) in bovine heart submitochondrial particles with an IC50 of 16.6±3 nmol/L that was comparable to the reference inhibitors of MC-1, rotenone, pyridaben, and deguelin (IC50 of 18.2±6.7 nmol/L, 19.8±2.6 nmol/L, and 23.1±1.5 nmol/L, respectively). F-18 BMS-747158-02 had high uptake in monolayers of neonatal rat cardiomyocytes (10.3%±0.7% of incubated drug at 60 minutes) that was inhibited by 200 nmol/L of rotenone (91%±2%) and deguelin (89%±3%). In contrast, an inactive pyridaben analog, P-0 (IC50 value>4 μmol/L in MC-1 assay), did not inhibit the binding of F-18 BMS-747158-02 in cardiomyocytes. Uptake and washout kinetics for F-18 BMS-747158-02 in rat cardiomyocytes indicated that the time to half-maximal (t1/2) uptake was very rapid (approximately 35 seconds), and washout t1/2 for efflux of F-18 BMS-747158-02 was greater than 120 minutes. In vivo biodistribution studies in mice showed that F-18 BMS-747158-02 had substatial myocardial uptake (9.5%±0.5% of injected dose per gram) at 60 minutes and heart-to-lung and heart-to-liver ratios of 14.1±2.5 and 8.3±0.5, respectively. Positron emission tomography imaging in the mouse allowed clear cardiac visualization and demonstrated sustained myocardial uptake through 55 minutes. Conclusions F-18 BMS-747158-02 is a novel positron emission tomography cardiac tracer targeting MC-I in cardiomyocytes with rapid uptake and slow washout. These characteristics allow fast and sustained accumulation in the heart.  相似文献   
129.
130.
Depressive symptoms are common in patients with neurodegenerative disorders. Imaging studies suggest that a disruption of frontal-subcortical pathways may underlie depression associated with basal ganglia disease. This pilot study tested the hypothesis that frontal dysfunction contributes to depression associated with multiple system atrophy (MSA) and progressive supranuclear palsy (PSP). Depressed patients with MSA (n = 11), PSP (n = 9), and age-matched controls (n = 25) underwent measures of cerebral glucose metabolism applying positron emission tomography with (18)F-fluorodeoxyglucose. Regional metabolism in the patient groups was compared to the normal subjects using the voxel-based statistical parametric mapping. Depressive symptom severity (Hamilton Depression Rating) and degree of locomotor disability (Hoehn & Yahr) were assessed in the patient groups. The association between prefrontal metabolism and the occurrence of depressive symptoms and the degree of locomotor disability was investigated. When compared to controls, MSA patients revealed significant metabolic decreases in bilateral frontal, parietal, and cerebellar cortex and in the left putamen. In PSP patients, significant hypometabolism was demonstrated in bilateral frontal cortex, right thalamus, and midbrain. Depression severity but not the patients' functional condition was significantly associated with dorsolateral prefrontal glucose metabolism in both patient groups. The findings of this pilot study support the hypothesis that depressive symptoms in MSA and PSP are associated with prefrontal dysfunction.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号